| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-291X(88)80091-3 |
| P8608 | Fatcat ID | release_46wdlcoe7ngz3mjm7rw3zh7c7a |
| P698 | PubMed publication ID | 3284526 |
| P2093 | author name string | Cohen A | |
| Petric M | |||
| Head S | |||
| Lingwood C | |||
| Waddell T | |||
| P2860 | cites work | Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities | Q24646436 |
| The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli | Q33457864 | ||
| Identification of UDP-galactose: lactose (lactosylceramide) alpha-4 and beta-3 galactosyltransferases in human kidney | Q34165941 | ||
| Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19. | Q39965419 | ||
| The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay | Q42015670 | ||
| Antigenic heterogeneity of Escherichia coli verotoxins | Q44354606 | ||
| Purification and physicochemical properties of a unique Vero cell cytotoxin from Escherichia coli O157:H7. | Q54775534 | ||
| Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli. | Q54791828 | ||
| Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages fromEscherichia coli933 | Q57563895 | ||
| The Hemolytic-Uremic Syndrome | Q69120193 | ||
| Two distinct toxins active on Vero cells from Escherichia coli O157 | Q69870583 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| ceramides | Q424213 | ||
| Verocytotoxin | Q7922328 | ||
| P304 | page(s) | 674-679 | |
| P577 | publication date | 1988-04-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. | |
| P478 | volume | 152 |
| Q27622010 | A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity |
| Q35104239 | A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit |
| Q57563866 | Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer |
| Q35109009 | Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II |
| Q33418526 | Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication |
| Q38354498 | Aglycone modulation of glycolipid receptor function |
| Q41285938 | Alpha 1,4galactosyltransferase activity and Gb3Cer expression in human leukaemia/lymphoma cell lines |
| Q36785336 | Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit |
| Q42941754 | Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs |
| Q90131552 | Bimodal Response to Shiga Toxin 2 Subtypes Results from Relatively Weak Binding to the Target Cell |
| Q37036097 | Binding of Pk-trisaccharide analogs of globotriaosylceramide to Shiga toxin variants. |
| Q33401560 | Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice |
| Q36363421 | CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis |
| Q56917430 | CD77: an antigen of germinal center B cells entering apoptosis |
| Q42859529 | Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron |
| Q33682932 | Characterization of protein-glycolipid recognition at the membrane bilayer. |
| Q39654288 | Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells |
| Q36215407 | Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine |
| Q50169925 | Clustering of PK-trisaccharides on amphiphilic cyclodextrin reveals unprecedented affinity for the Shiga-like toxin Stx2. |
| Q77390584 | Comparison of 14 PCR systems for the detection and subtyping of stx genes in Shiga-toxin-producing Escherichia coli |
| Q34527617 | Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems |
| Q51680443 | Comparison of Shiga-like toxin II expression between two genetically diverse lineages of Escherichia coli O157:H7. |
| Q36977977 | Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants |
| Q33605233 | Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice |
| Q27644365 | Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli |
| Q40214420 | Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1 |
| Q34534278 | Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. |
| Q33498793 | Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. |
| Q33752654 | Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice |
| Q39551583 | Enterohaemorrhagic Escherichia coli O157:H7 Shiga-like toxin 1 is required for full pathogenicity and activation of the p38 mitogen-activated protein kinase pathway in Caenorhabditis elegans. |
| Q36195757 | Enterotoxins in acute infective diarrhoea |
| Q34031212 | Erythrocyte and porcine intestinal glycosphingolipids recognized by F4 fimbriae of enterotoxigenic Escherichia coli |
| Q56765607 | Escherichia coli O157:H7 as an emerging foodborne pathogen: a literature review |
| Q35816742 | Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood |
| Q39655730 | Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose) polymerase via in vitro activation of caspases |
| Q39195548 | Escherichia coli, cattle and the propagation of disease |
| Q41118137 | Establishment of a monoclonal antibody directed against Gb3Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells |
| Q35779632 | Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity |
| Q35381150 | Expression and purification of Shiga-like toxin II B subunits. |
| Q38024274 | Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature |
| Q34372184 | Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis. |
| Q33330688 | Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology |
| Q67493240 | Glycosphingolipids: the putative receptor for Staphylococcus aureus enterotoxin-B in human kidney proximal tubular cells |
| Q34290908 | Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide. |
| Q30305685 | Human platelet aggregation is not altered by Shiga toxins 1 or 2. |
| Q34663367 | Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae |
| Q35592357 | Implication of virulence factors in Escherichia coil O157:H7 pathogenesis |
| Q33545441 | In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2. |
| Q38323354 | In vitro assessment of a chemically synthesized Shiga toxin receptor analog attached to chromosorb P (Synsorb Pk) as a specific absorbing agent of Shiga toxin 1 and 2. |
| Q37006892 | In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity |
| Q33837961 | Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide |
| Q36634680 | Infection by verocytotoxin-producing Escherichia coli |
| Q38359579 | Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes |
| Q33921062 | Interaction of ricin and Shiga toxins with ribosomes |
| Q35490172 | Interaction of verotoxin 2e with pig intestine. |
| Q87084747 | Interfering parameters in the determination of urinary globotriaosylceramide (Gb3) in patients with chronic kidney disease |
| Q35583685 | Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms |
| Q35531436 | Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. |
| Q33362481 | Marasmius oreades lectin induces renal thrombotic microangiopathic lesions |
| Q44747682 | Membrane curvature induced by proximity of anionic phospholipids can initiate endocytosis |
| Q41994849 | Modeling neutralization of Shiga 2 toxin by A-and B-subunit-specific human monoclonal antibodies |
| Q37009028 | Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract |
| Q36986374 | Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7 |
| Q52040660 | Neutral glycolipids of human and bovine milk |
| Q39857916 | Neutral red assay for measurement of quantitative vero cell cytotoxicity |
| Q30434555 | New developments in enteric bacterial toxins |
| Q55416818 | Non-pathogenic Escherichia coli Enhance Stx2a Production of E. coli O157:H7 Through Both bamA-Dependent and Independent Mechanisms. |
| Q45885369 | Oral immunization with a shiga toxin B subunit: rotavirus NSP4(90) fusion protein protects mice against gastroenteritis |
| Q24550740 | Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections |
| Q67913265 | Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function |
| Q39824053 | Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. |
| Q37007284 | Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies |
| Q37174239 | Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor |
| Q33397981 | Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes |
| Q35673972 | Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin. |
| Q33495149 | Regulation of the Shiga-like toxin II operon in Escherichia coli |
| Q33967696 | Relationship of genetic type of Shiga toxin to manifestation of bloody diarrhea due to enterohemorrhagic Escherichia coli serogroup O157 isolates in Osaka City, Japan |
| Q37953290 | Ricin and Shiga toxins: effects on host cell signal transduction |
| Q33563140 | Selective Evolution of Ligands by Exponential Enrichment to Identify RNA Aptamers against Shiga Toxins |
| Q38361388 | Self-assembled monolayers of globotriaosylceramide (Gb3) mimics: surface-specific affinity with shiga toxins |
| Q40200136 | Sensitive receptor-specified enzyme-linked immunosorbent assay for Escherichia coli verocytotoxin |
| Q36973479 | Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin |
| Q48247684 | Sex- and age-related differences in ceramide dihexosides of primary human brain tumors |
| Q27021676 | Shiga Toxin (Stx) Classification, Structure, and Function |
| Q33963113 | Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation |
| Q36382092 | Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib |
| Q34163196 | Shiga toxin binding to glycolipids and glycans |
| Q27738268 | Solution structure of the carbohydrate-binding B-subunit homopentamer of verotoxin VT-1 from E. coli |
| Q42067761 | Subtilase cytotoxin, produced by Shiga-toxigenic Escherichia coli, transiently inhibits protein synthesis of Vero cells via degradation of BiP and induces cell cycle arrest at G1 by downregulation of cyclin D1 |
| Q33372310 | Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? |
| Q38160938 | The Canadian contribution to the science of verotoxigenic Escherichia coli and associated illnesses: the early years |
| Q38640768 | The Epinephrine/Norepinephrine/Autoinducer-3 Interkingdom Signaling System in Escherichia coli O157:H7. |
| Q40552744 | The P blood group system: biochemical, serological, and clinical aspects |
| Q90725270 | The Symmetry of Viral Sialic Acid Binding Sites-Implications for Antiviral Strategies |
| Q57704288 | The hemolytic uremic syndrome |
| Q47798097 | The synthesis of 16-mercaptohexadecanyl glycosides for biosensor applications. |
| Q90128191 | Tissue Responses to Shiga Toxin in Human Intestinal Organoids |
| Q39829974 | Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits. |
| Q37608531 | Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli |
| Q54590916 | Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. |
| Q35689027 | Two distinct cytotoxic activities of subtilase cytotoxin produced by shiga-toxigenic Escherichia coli |
| Q40782927 | Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli). |
| Q30441434 | p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cells |
Search more.